Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apolipoprotein E4 is a critical fat-binding protein involved in systemic and cerebral lipid homeostasis whose structural properties distinguish it from other isoforms. Its presence significantly increases susceptibility to late-onset Alzheimer’s disease through complex effects on cellular lipid handling and neuronal health while also impacting cardiovascular risk profiles due to its fundamental metabolic roles.
Modulation of lipid metabolism and amyloid plaque dynamics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apolipoprotein E4 (APOE4).